Wintershall Dea Sale to Be Reviewed, German Econ Minister Says
By Andrea Thomas
BASF's planned sale of the exploration and production business of its subsidiary Wintershall Dea to Harbour Energy will be reviewed for its potential impact on German security interests, according to Economics Minister Robert Habeck.
Habeck told the German parliament on Wednesday that the government reviews corporate investments and divestments with an eye to whether national security might be jeopardized by a cross-border transaction.
At the end of December, BASF agreed to sell Wintershall Dea's exploration and production business to the U.K.'s Harbour Energy, in a transaction valued at $11.2 billion.
Industry group Zukunft Gas expressed concerns over the deal.
"Germany will be dependent on natural gas for many years to come, so Wintershall Dea and its domestic gas production play an important role in the transformation of the energy system," Zukunft Gas head, Timm Kehler, said.
Nina Kienle contributed to the article.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
January 17, 2024 13:09 ET (18:09 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks